Xcout Intel
Nervonik
Nervonik is a medical technology company headquartered in Los Angeles, California, focusing on neuromodulation devices. The company develops next-generation peripheral nerve stimulation technology engineered to integrate dynamic stimulation for high-motion activities.
Subscribe to see Nervonik’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Nervonik at a glance
Nervonik is a therapeutic devices company headquartered in United States. It has raised at least $65.5M across the 2 funding rounds on record. Its most recent funding round, Series A, raised $52.5M in April 2026. Xcout tracks 4 named people at Nervonik, including Dan Brounstein (Chief Strategy and Marketing Officer).
Nervonik leadership
- Dan BrounsteinChief Strategy and Marketing Officer
- Rob DiTotaChief Commercial Officer
- Aydin BabakhaniFounder and Chief Executive Officer
- Patrick MartinVice President, Clinical Affairs
Nervonik funding rounds
At least $65.5M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $52.5M | 5 named | |
| Series A | $13M | 3 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Nervonik competitors
A few of Nervonik's closest competitors — see the full list of competitors and alternatives →
Nalu Medical, Inc. is a privately held commercial medical device company based in Carlsbad, California. The company specializes in developing the Nalu neurostimulation system as a battery-free, long-term solution for chronic nerve pain.
Nevro Corp. is headquartered in Redwood City, California, and provides medical technologies and patient education focused on its proprietary HFX therapy.
Bioness Medical, Inc. is a medical technology provider headquartered in Valencia, California. Founded in 2004, the company specializes in innovative rehabilitation technologies, such as functional electrical stimulation, to help individuals with neurological conditions regain mobility and independence.
Neurinnov is a medical technology company based in Montpellier, France, specializing in innovation within neurostimulation. The firm has developed a versatile technology platform designed to restore human functions in individuals suffering from functional deficiencies across multiple pathologies. Through its specialized medical research, the company creates clinical value and therapeutic solutions.
Get Nervonik's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Nervonik in Xcout Intel
- 4 named people with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access